ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 742629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 742629; 2) Community: the network communities that were significantly associated with the response to NSC 742629; 3) Molecule: the relationships between components within communities and NSC 742629; 4) MDR: the compounds that were significantly associated with the NSC 742629.

NSC Compound Enrichment Correlation
NSC 686783 Null 0.024225674400439 0.26850693
NSC 726112 12-(4'-Phthalimidobutylidene)-5,6-dihydro-5,11-diketo-2,3-di methoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquin oline 0.024225674400439 0.30223954
NSC 726367 Null 0.024225674400439 0.04052109
NSC 728979 6-(3-Azidopropyl)-5,6-dihydro-8,9-methylenedioxy-3-nitro-5,1 1-dioxo-11H-indeno[1,2-c]isoquinoline 0.024225674400439 0.57375636
NSC 730690 Null 0.024225674400439 -0.083499066
NSC 745098 21-[2-(N,N-dimethylamino)ethyl]-oxy-.7.alpha.-methyl-19-norpregna-1,3,5(10),17(20)-tetraen-3-ol citrate salt 0.024225674400439 0.34637767
NSC 761826 (Z)-3-((1-(4-fluoro-3-methoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.024225674400439 0.053375836
NSC 320846 Batracylin, Daniquidone 0.0247898374452139 0.49408031
NSC 48300 ANTINEOPLASTIC-48300 0.0247898374452139 0.36631986
NSC 610456 Camptothecin Derivative 0.0247898374452139 0.77558951
Total:76  Current:35    [First] [Prev] [Next] [Last]